Study Confirms Efficacy of Guselkumab Treatment of Psoriasis After Ustekinumab Discontinuation

These multicenter, retrospective data highlight the use of guselkumab after discontinuing ustekinumab treatment up to 156 weeks of use.

Related Keywords

Italy ,Matteo Megna ,University Of Naples Federico ,Naples Federico ,Psoriasis Activity Severity Index ,Dermatology Life Quality Index ,